Hydroxychloroquine in the treatment of outpatients with mildly symptomatic COVID-19: a multi-center observational study

BACKGROUND: Hydroxychloroquine has not been associated with improved survival among hospitalized COVID-19 patients in the majority of observational studies and similarly was not identified as an effective prophylaxis following exposure in a prospective randomized trial. We aimed to explore the role...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:BMC Infect Dis
Main Authors: Ip, Andrew, Ahn, Jaeil, Zhou, Yizhao, Goy, Andre H., Hansen, Eric, Pecora, Andrew L., Sinclaire, Brittany A., Bednarz, Urszula, Marafelias, Michael, Sawczuk, Ihor S., Underwood, Joseph P., Walker, David M., Prasad, Rajiv, Sweeney, Robert L., Ponce, Marie G., La Capra, Samuel, Cunningham, Frank J., Calise, Arthur G., Pulver, Bradley L., Ruocco, Dominic, Mojares, Greggory E., Eagan, Michael P., Ziontz, Kristy L., Mastrokyriakos, Paul, Goldberg, Stuart L.
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2021
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7807228/
https://ncbi.nlm.nih.gov/pubmed/33446136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-021-05773-w
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים